<DOC>
	<DOC>NCT02371707</DOC>
	<brief_summary>This study aims to establish bioequivalence between two tablet formulations of idalopirdine</brief_summary>
	<brief_title>Bioequivalence Study of Idalopirdine Tablets 60 mg</brief_title>
	<detailed_description />
	<criteria>Healthy men and women ≥18 and ≤55 years of age body mass index (BMI) of &gt;18.5 and &lt;30 kg/m2 Pregnant and lactating women Other protocol defined inclusion and exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>